Acute post-streptococcal glomerulonephritis in children-treatment standard

Area of Science:

• Pediatric Nephrology
• Infectious Diseases
• Immunology

Background:

• Acute post-streptococcal glomerulonephritis (APSGN) is the primary cause of acute glomerulonephritis in children globally.
• Incidence is decreasing in developed nations due to improved sanitation and hygiene but remains a significant issue in low- and middle-income countries.
• APSGN pathogenesis involves immune complex-mediated activation of the alternate complement pathway, leading to glomerular inflammation and kidney injury.

Purpose of the Study:

• To review current treatment standards for acute post-streptococcal glomerulonephritis in children.
• To discuss novel developments in pathophysiology, diagnosis, outcome prediction, and management of APSGN.
• To highlight the importance of preventing streptococcal infections and managing complications.

Main Methods:

• Review of current literature on acute post-streptococcal glomerulonephritis.
• Analysis of diagnostic criteria and treatment approaches.
• Discussion of emerging trends in understanding and managing APSGN.

Main Results:

• APSGN typically presents as acute nephritic syndrome, with potential complications including hypertensive emergencies and acute kidney injury.
• Management focuses on supportive care, diuretics, and antihypertensives; immunosuppressants and kidney replacement therapy are rarely needed.
• Most children achieve full recovery, but long-term monitoring for proteinuria, hypertension, and chronic kidney disease progression is sometimes necessary.

Conclusions:

• Prompt diagnosis, management of complications, and supportive care are crucial for favorable outcomes in pediatric APSGN.
• Kidney biopsies are infrequently required, reserved for complex or atypical cases.
• Continued research into pathophysiology and novel treatments is essential for improving patient care and predicting outcomes.